Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Heart Rhythm. 2013 Dec 27;11(4):697–706. doi: 10.1016/j.hrthm.2013.12.032

Figure 6.

Figure 6

Glibenclamide (Glib) terminates ES. Pseudo-ECGs (upper panels) and Vm/Cai tracings at the maximal ΔCaiTD50−APD50 site (squares) before and after addition of Glib are shown. Note that Glib prolonged the post-defibrillation APD50, which decreased ΔCaiTD50−APD50 and prevented SVF.